141 related articles for article (PubMed ID: 36963273)
1. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
[TBL] [Abstract][Full Text] [Related]
2. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
3. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas.
Schoedel K; Miller V; Osei-Hwedieh D; Watters R; Duensing A; John I; Chandran U; Chang A; Soman V; Weiss K
J Bone Oncol; 2021 Aug; 29():100370. PubMed ID: 34094840
[TBL] [Abstract][Full Text] [Related]
5. Benign looking giant cell component in dedifferentiated chondrosarcoma: benign or malignant? A case report.
Huang J; Jiang Z; Yang Q; Zhang H
Int J Surg Pathol; 2013 Feb; 21(1):48-53. PubMed ID: 22736299
[TBL] [Abstract][Full Text] [Related]
6. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract][Full Text] [Related]
7. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes.
Rozeman LB; de Bruijn IH; Bacchini P; Staals EL; Bertoni F; Bovée JV; Hogendoorn PC
Mod Pathol; 2009 Nov; 22(11):1489-98. PubMed ID: 19734846
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated chondrosarcoma of bone with prominent rhabdoid component.
Stemm M; Beck C; Mannem R; Neilson J; Klein MJ
Ann Diagn Pathol; 2017 Jun; 28():7-11. PubMed ID: 28648942
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
[TBL] [Abstract][Full Text] [Related]
12. Dedifferentiated chondrosarcoma mimicking a giant cell tumor. Is this low grade dedifferentiated chondrosarcoma?
Knösel T; Werner M; Jung A; Kirchner T; Dürr HR
Pathol Res Pract; 2014 Mar; 210(3):194-7. PubMed ID: 24405942
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma.
Shimada E; Matsumoto Y; Nakagawa M; Susuki Y; Endo M; Setsu N; Fujiwara T; Iida K; Nabeshima A; Yahiro K; Kimura A; Hirose T; Kanahori M; Oyama R; Oda Y; Nakashima Y
Br J Cancer; 2022 May; 126(9):1289-1300. PubMed ID: 35017658
[TBL] [Abstract][Full Text] [Related]
15. Clonality analysis and
Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated chondrosarcoma with rhabdomyosarcomatous differentiation.
Reith JD; Bauer TW; Fischler DF; Joyce MJ; Marks KE
Am J Surg Pathol; 1996 Mar; 20(3):293-8. PubMed ID: 8772782
[TBL] [Abstract][Full Text] [Related]
17. Potential sampling error in fine needle aspiration biopsy of dedifferentiated chondrosarcoma: a report of 4 cases.
Rinas AC; Ward WG; Kilpatrick SE
Acta Cytol; 2005; 49(5):554-9. PubMed ID: 16334036
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
[TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated chondrosarcoma of the cervical spine: a case report.
Matsumoto Y; Takahashi Y; Harimaya K; Nakagawa T; Kawaguchi K; Okada S; Hayashida M; Doi T; Sakamoto A; Matsunobu T; Oda Y; Iwamoto Y
World J Surg Oncol; 2013 Feb; 11():32. PubMed ID: 23375124
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
